Reversine是一种 ATP-竞争性的 Aurora kinase 抑制剂,抑制 Aurora A、Aurora B 和 Aurora C,IC50分别为 400、500 和 400 nM。Reversine诱导谱系特定的小鼠肌母细胞去分化为具有成骨和成脂潜能的多能前体细胞,诱导小鼠和人类皮肤成纤维细胞去分化为具有肌原基潜能的细胞,诱导纤维环细胞去分化为具有潜力沿软骨形成、成骨或成脂谱系发展的多能间充质前体细胞。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | Aurora A ↓ ↑ | Aurora B ↓ ↑ | Aurora C ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BI-847325 |
++
Aurora A (Human), IC50: 25 nM |
++++
Aurora B (Xenopus laevis), IC50: 3 nM |
++
Aurora C (Human), IC50: 15 nM |
99%+ | |||||||||||||||
| CCT 137690 |
++
Aurora A, IC50: 15 nM |
++
Aurora B, IC50: 25 nM |
++
Aurora C, IC50: 19 nM |
99%+ | |||||||||||||||
| MK-5108 |
++++
Aurora A, IC50: 0.064 nM |
99%+ | |||||||||||||||||
| KW-2449 |
+
Aurora A, IC50: 48 nM |
FLT3 | 99%+ | ||||||||||||||||
| Tozasertib |
++++
Aurora A, Ki app: 0.6 nM |
++
Aurora B, Ki app: 18 nM |
+++
Aurora C, Ki app: 4.6 nM |
Bcr-Abl,FLT3 | 99%+ | ||||||||||||||
| AT9283 |
++++
Aurora A, IC50: ~3.0 nM |
++++
Aurora B, IC50: ~3.0 nM |
99%+ | ||||||||||||||||
| MLN8054 |
+++
Aurora A, IC50: 4 nM |
+
Aurora B, IC50: 172 nM |
99%+ | ||||||||||||||||
| ZM-447439 |
+
Aurora A, IC50: 110 nM |
+
Aurora B, IC50: 130 nM |
Src | 99%+ | |||||||||||||||
| TCS7010 |
++++
Aurora A, IC50: 3.4 nM |
99%+ | |||||||||||||||||
| TAK-901 |
++
Aurora A-TPX2, IC50: 21 nM |
++
Aurora B-INCENP, IC50: 15 nM |
99%+ | ||||||||||||||||
| Danusertib |
+++
Aurora A, IC50: 13 nM |
+
Aurora B, IC50: 79 nM |
+
Aurora C, IC50: 61 nM |
RET | 99%+ | ||||||||||||||
| MK-8745 |
++++
Aurora A, IC50: 0.6 nM |
99+% | |||||||||||||||||
| PHA-680632 |
++
Aurora A, IC50: 27 nM |
+
Aurora B, IC50: 135 nM |
+
Aurora C, IC50: 120 nM |
FLT3 | 99%+ | ||||||||||||||
| AMG 900 |
+++
Aurora A, IC50: 5 nM |
+++
Aurora B, IC50: 4 nM |
++++
Aurora C, IC50: 1 nM |
99%+ | |||||||||||||||
| Alisertib |
++++
Aurora A, IC50: 1.2 nM |
99%+ | |||||||||||||||||
| ENMD-2076 |
+++
Aurora A, IC50: 14 nM |
+
Aurora B, IC50: 350 nM |
RET,FLT3 | 98% | |||||||||||||||
| JNJ-7706621 |
+++
Aurora A, IC50: 11 nM |
++
Aurora B, IC50: 15 nM |
99%+ | ||||||||||||||||
| CYC-116 |
+++
Aurora A, Ki: 8 nM |
+++
Aurora B, Ki: 9 nM |
FLT3 | 99%+ | |||||||||||||||
| Reversine |
+++
Aurora A, IC50: 12 nM |
+++
Aurora B, IC50: 13 nM |
++
Aurora C, IC50: 20 nM |
98% | |||||||||||||||
| CCT129202 |
++
Aurora A, IC50: 42 nM |
+
Aurora B, IC50: 198 nM |
+
Aurora C, IC50: 227 nM |
98% | |||||||||||||||
| SNS-314 mesylate |
+++
Aurora A, IC50: 9 nM |
++
Aurora B, IC50: 31 nM |
++++
Aurora C, IC50: 3 nM |
99%+ | |||||||||||||||
| Barasertib-HQPA |
++++
Aurora B, IC50: 0.37 nM |
99%+ | |||||||||||||||||
| Hesperadin |
+
Aurora B (human), IC50: 250 nM |
98% | |||||||||||||||||
| GSK-1070916 |
++++
Aurora B-INCENP, IC50: 3.5 nM |
+++
Aurora C-INCENP, IC50: 6.5 nM |
Tie-2,SIK | 99% | |||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 产品名称 | Adenosine Receptor ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ZM241385 | ✔ | 99%+ | |||||||||||||||||
| Istradefylline |
+++
Adenosine A2A receptor, Ki: 2.2 nM |
98% | |||||||||||||||||
| Reversine |
+
human A3 adenosine receptor, Ki: 0.66 μM |
98% | |||||||||||||||||
| SCH58261 |
++++
rat A2a, Ki: 2.3 nM bovine A2a, Ki: 2.0 nM |
99%+ | |||||||||||||||||
| A2A receptor antagonist 1 |
++
A2AR, Ki: 4 nM A1R, Ki: 264 nM |
99%+ | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 靶点 |
|
| 描述 | Reversine, an innovative inhibitor of Aurora kinases, prevents colony formation in human acute myeloid leukemia cells. It strongly inhibits Aurora kinases A and B and moderately inhibits Aurora kinase C at a concentration of 0.5 μM. In further testing, Reversine shows an IC50 of 400 nM for Aurora kinase A, 500 nM for B, and 400 nM for C, while showing limited inhibition on other tested kinases. Additionally, the IC50 for MEK1 is >1.5 μM and for muscle myosin is 350 nM[1]. |
| 体内研究 | The Reversine and Aspirin combination effectively triggers cell cycle arrest and apoptosis. To assess its anti-tumor efficacy, we established a xenograft nude mouse model via subcutaneous injection. Around 16 days post-tumor inoculation, mice implanted with cervical cancer cells experienced a roughly 10% reduction in initial body weight. Nonetheless, tumor growth (tumor weight) was notably diminished, and the survival rate extended in the combination treatment group[2]. |
| 体外研究 | Reversine, an innovative inhibitor of Aurora kinases, prevents colony formation in human acute myeloid leukemia cells. It strongly inhibits Aurora kinases A and B and moderately inhibits Aurora kinase C at a concentration of 0.5 μM. In further testing, Reversine shows an IC50 of 400 nM for Aurora kinase A, 500 nM for B, and 400 nM for C, while showing limited inhibition on other tested kinases. Additionally, the IC50 for MEK1 is >1.5 μM and for muscle myosin is 350 nM[1]. |
| Concentration | Treated Time | Description | References | |
| ANJEA-CD | 5 µM | 30 minutes | Inhibit ANJEA kinase activity | Plant Biotechnol J. 2023 Jan;21(1):63-77. |
| FER-CD | 5 µM | 30 minutes | Inhibit FER kinase activity | Plant Biotechnol J. 2023 Jan;21(1):63-77. |
| HERK1-CD | 5 µM | 30 minutes | Inhibit HERK1 kinase activity | Plant Biotechnol J. 2023 Jan;21(1):63-77. |
| THE1-CD | 5 µM | 30 minutes | Inhibit THE1 kinase activity | Plant Biotechnol J. 2023 Jan;21(1):63-77. |
| DDX11/C0 cells | 100 nM | 1 day | Reversine accelerated mitosis, reducing APC3 knockdown-induced cell death and spindle checkpoint-dependent arrest. | Nat Commun. 2015 Oct 1;6:8399. |
| OC2 cells | 1 µM | 12 hours | To evaluate the effect of Reversine on OC2 cell growth, results showed that Reversine significantly suppressed cell proliferation. | J Biomed Sci. 2012 Jan 27;19(1):9. |
| OCSL cells | 1 µM | 12 hours | To evaluate the effect of Reversine on OCSL cell growth, results showed that Reversine significantly suppressed cell proliferation. | J Biomed Sci. 2012 Jan 27;19(1):9. |
| Bovine ear marginal tissue fibroblasts | 20 nM | 2 days | Reversine-treated fibroblasts acquired the differentiation potential for neural lineage under neural-inducing (NID) conditions and expressed neural-specific markers. | Int J Biol Sci. 2016 Jan 1;12(1):53-62. |
| HCT116 colon cancer cells | 1 µM | 24 hours | To investigate the effect of Reversine on caspase-2 activity in HCT116 cells, the results showed that Reversine induced caspase-2 activation and led to the cleavage of MDM-2 protein. | Cell Death Differ. 2019 Dec;26(12):2695-2709. |
| C2C12 myoblasts | 20 nM | 4 days | Inhibits the differentiation of C2C12 myoblasts, preventing myotube formation, and increases their plasticity, allowing them to differentiate into osteoblasts and adipocytes under specific inducing conditions. | Proc Natl Acad Sci U S A. 2007 Jun 19;104(25):10482-7. |
| 3T3E1 osteoblasts | 300 nM | 4 days | Increases the plasticity of 3T3E1 osteoblasts, allowing them to differentiate into adipocytes under adipocyte-inducing conditions. | Proc Natl Acad Sci U S A. 2007 Jun 19;104(25):10482-7. |
| Human primary skeletal myoblasts | 300 nM | 4 days | Increases the plasticity of human primary skeletal myoblasts, allowing them to differentiate into osteoblasts and adipocytes under specific inducing conditions. | Proc Natl Acad Sci U S A. 2007 Jun 19;104(25):10482-7. |
| Bovine ear marginal tissue fibroblasts | 5 µM | 4 days | Reversine-treated fibroblasts acquired a drastically different morphology, transformed from spindle shape into considerably larger in size, flatter, and more adhesive to the culture plate, and displayed marked cell swelling and polyploid cell formation. | Int J Biol Sci. 2016 Jan 1;12(1):53-62. |
| CHO cells | 1000 nM | 48 hours | Reversine combined with PTX significantly improved micronucleation efficiency in CHO cells and reduced cytotoxicity. | Nucleic Acids Res. 2024 Feb 9;52(3):1498-1511. |
| HFL1-iPS cells | 1000 nM | 48 hours | Reversine combined with PTX significantly improved micronucleation efficiency in HFL1-iPS cells and reduced cytotoxicity. | Nucleic Acids Res. 2024 Feb 9;52(3):1498-1511. |
| MCF-7 cells | 5 µM | 48 hours | Reversine inhibited MCF-7 cell proliferation, particularly at the tumor-stroma interface, but no additional anti-proliferative effect was observed in the bulk region. | Nat Commun. 2014 Dec 9;5:5662. |
| Mouse embryo cells | 0.5 µM | 8- to 16-cell division | Observe chromosome segregation errors, found that 48% of reversine-treated blastomeres exhibited lagging chromosomes and micronuclei formation during mitosis | Nat Commun. 2016 Mar 29;7:11165. |
| Mouse embryo cells | 0.5 µM | four- to eighourst-cell division | Induce chromosome segregation errors, generate aneuploid cells, resulting in embryo death during peri-implantation development | Nat Commun. 2016 Mar 29;7:11165. |
| Mouse pre-implantation embryos | 0.5 µM | four- to eighourst-cell division stage | Induced chromosome segregation errors, generating aneuploid cells and leading to embryo death during peri-implantation development. | Nat Commun. 2016 Mar 29;7:11165. |
| HeLa cells | 0.5 µM | Inhibits MPS1 autophosphorylation, causing chromosome alignment defects, but does not affect P-S10-H3 levels | J Cell Biol. 2010 Jul 12;190(1):73-87. | |
| HeLa cells | 1 µM | Completely overrides the spindle checkpoint in the presence of 3.3 µM nocodazole, causing MAD1 and the RZZ complex to fail to localize to kinetochores | J Cell Biol. 2010 Jul 12;190(1):73-87. | |
| Administration | Dosage | Frequency | Description | References | ||
| NOD/SCID mice | MCF-7 breast cancer model | Intraperitoneal injection | 0.5 mg/kg | Twice a week for 8 weeks | Reversine treatment inhibited MCF-7 tumor growth and bone metastasis, reducing tumor stromalization including collagen deposition and recruitment of activated stromal cells. | Nat Commun. 2014 Dec 9;5:5662. |
| Mice | Chromosome mosaicism model | In embryo culture medium | 0.5 mM | Four- to eight-cell division stage, followed by culture in inhibitor-free medium until the mature blastocyst stage | To investigate the fate of aneuploid cells and the developmental potential of mosaic embryos, it was found that mosaic embryos have full developmental potential provided they contain sufficient euploid cells. | Nat Commun. 2016 Mar 29;7:11165. |
| Mice | Chromosome mosaicism model | In vitro culture | 0.5 mM | Four- to eight-cell division | Investigate the fate of aneuploid cells and the developmental potential of mosaic embryos, found that reversine-treated embryos died during early postimplantation stages, but mosaic embryos containing sufficient normal euploid cells have full developmental potential | Nat Commun. 2016 Mar 29;7:11165. |
| SCID/Beige mice | Model of diffuse MM lesions | Intravenous injection | 1 mg/kg | Twice weekly | Reversine significantly reduced tumor burden in the diffuse myeloma bone lesion model | Nat Med. 2010 Apr;16(4):483-9 |
| Arabidopsis | Arabidopsis seedlings | Root treatment | 5 μM | 24 hours | Enhanced innate immunity in plant roots and thus alleviated soil-borne diseases | Plant Biotechnol J. 2023 Jan;21(1):63-77. |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.54mL 0.51mL 0.25mL |
12.71mL 2.54mL 1.27mL |
25.41mL 5.08mL 2.54mL |
|
| CAS号 | 656820-32-5 |
| 分子式 | C21H27N7O |
| 分子量 | 393.49 |
| SMILES Code | C12=NC(NC3=CC=C(N4CCOCC4)C=C3)=NC(NC5CCCCC5)=C1N=CN2 |
| MDL No. | MFCD09953189 |
| 别名 | |
| 运输 | 蓝冰 |
| InChI Key | ZFLJHSQHILSNCM-UHFFFAOYSA-N |
| Pubchem ID | 210332 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, inert atmosphere, 2-8°C |
| 溶解方案 |
DMSO: 18 mg/mL(45.75 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
沪公网安备 31011702889066号
沪ICP备2024050318号-1